The fundamental mechanism might be that loss-of-function mutations of CDKN2A lead to loss of both proteins encoded by it, p14ARF and p16INK4a, releasing G1/S and G2/M cell-cycle checkpoints and resulting in uninhibited cell proliferation and tumor formation (24). The gene discussed is CDKN2A; the disease is neoplasm.